PepGen Inc.
PEPG Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$2.52
KIRA · Stoqly’s AI analyst, in plain words
- PepGen Inc. lost $89.7M in fiscal 2025.
- Free cash flow was −$81.9M in fiscal 2025, — of revenue.
Market cap
$174M
P/E
—
Revenue
—
Net income
−$89.7M
Free cash flow
−$81.9M
Operating margin
—
PepGen Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$89.7M
No. It lost money last year.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What PepGen Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 4, 2026
- Legal name
- PepGen Inc.
- CIK
- 0001835597
PepGen Inc. · PEPG
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$27.3M | −$69.1M | −$78.6M | −$90.0M | −$89.7M |
| Diluted EPS | −$30.27 | −$4.42 | −$3.30 | −$2.85 | −$2.12 |
| Cash | |||||
| Cash from operations | −$22.6M | −$59.3M | −$69.0M | −$82.4M | −$81.6M |
| Capital expenditure | $0.5M | $3.8M | $2.6M | $0.5M | $0.3M |
| Free cash flow | −$23.1M | −$63.0M | −$71.6M | −$82.9M | −$81.9M |
| Share count change | — | 1,635.6% | 52.2% | 32.7% | 33.7% |
| Debt and strength | |||||
| Cash and short-term investments | $133M | $182M | $110M | $120M | $148M |
| Shareholders' equity | −$32.1M | $180M | $108M | $119M | $147M |
| Current ratio | 13.6x | 9.9x | 6.4x | 7.4x | 11.9x |
| Returns and quality | |||||
| Return on equity | — | −93.7% | −54.6% | −79.3% | −67.4% |
| Return on tangible equity | — | −38.5% | −72.5% | −75.9% | −60.8% |
| Altman Z'' | 0.7 | 6.4 | −0.5 | −1.7 | 0.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.1M
4 insiders
Of sales under plans
100%
$0.1M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
PepGen Inc. · PEPG
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.52 a share, the company is worth $174M.
Source: SEC EDGAR XBRL filings (CIK 0001835597). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.